Zhiyong Luo

Title: Zhiyong Luo: Innovator in CRF Receptor Antagonists

Introduction

Zhiyong Luo is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of CRF receptor antagonists. His work has implications for treating various disorders, showcasing his innovative approach to medical science.

Latest Patents

Zhiyong Luo holds a patent for "CRF receptor antagonists and methods relating thereto." This patent describes CRF receptor antagonists that are useful in treating disorders characterized by hypersecretion of CRF in warm-blooded animals, such as stroke. The patent outlines the structure of these antagonists, including stereoisomers, prodrugs, and pharmaceutically acceptable salts. Additionally, it discusses compositions containing a CRF receptor antagonist combined with a pharmaceutically acceptable carrier, along with methods for their use.

Career Highlights

Zhiyong Luo has had a distinguished career, working at SmithKline Beecham (Cork) Ltd. His expertise in pharmacology and innovative research has led to advancements in therapeutic options for various medical conditions. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Zhiyong has collaborated with notable colleagues, including Deborah Slee and John Patrick Williams. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Zhiyong Luo's contributions to the field of pharmacology, particularly through his patent on CRF receptor antagonists, highlight his role as an innovator. His work continues to influence the treatment of critical disorders, demonstrating the importance of innovation in medical science.